| Literature DB >> 34658314 |
Ruiqiang Li1, Yuxia Ma1, Wenqiang Zhan2, Xin Huang1, Zechen Zhang1, Meiqi Zhou1, Wei Bao1, Qingxia Li1.
Abstract
We assessed the association between the dietary inflammatory index (DII) and the development of metabolic syndrome in the elderly over 55 years in Northern China. The data of 1936 Chinese adults aged 55 years and over from a community-based neurological disease cohort study from 2018 to 2019 were analysed. Multiple logistic regression and restricted cubic splines regression were used for analysis, and social demographics, lifestyle and health-related factors were adjusted. In the fully adjusted model, the risk of metabolic syndrome increased by 1·28-fold in people with a pro-inflammatory diet. When we divide the metabolic syndrome by its components, high pro-inflammatory diet and hyperglycaemia, TAG, hypertension and abdominal obesity, we failed to observe a significant association between a high pro-inflammatory diet and HDL-cholesterol. However, these associations are moving in the expected direction. At the same time, the results of BMI subgroup analysis showed that with the increase of DII, obese people are at increased risk of metabolic syndrome, hyperglycaemia, high TAG, hypertension and abdominal obesity. Also in overweight people, the increase in DII is accompanied by an increased risk of hyperglycaemia and abdominal obesity. Higher inflammatory diet is related to metabolic syndrome, hypertension, hyperglycaemia, abdominal obesity and hypertriglyceridaemia. Further research is needed to confirm the role of inflammation and diet in the development of metabolic syndrome; however, it is desirable to reduce the dietary components associated with inflammation.Entities:
Keywords: Diet; Dietary inflammatory index; Elderly; Metabolic syndrome; Nutrition
Year: 2021 PMID: 34658314 PMCID: PMC9381302 DOI: 10.1017/S0007114521004207
Source DB: PubMed Journal: Br J Nutr ISSN: 0007-1145 Impact factor: 4.125
Fig. 1.Selection process of subjects.
Baseline characteristics and components of metabolic syndrome of the community cohort study of nervous system diseases (CCSNSD) project population across quartiles of the DII score(Frequency and percentages; median values and interquartile range)
| Quartile 1 ( | Quartile 2 ( | Quartile 3 ( | Quartile 4 ( | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Characteristic | Frequency | % | Frequency | % | Frequency | % | Frequency | % |
|
| Age (years) | < 0·001 | ||||||||
| Median | 68 | 65 | 63 | 64 | |||||
| IQR | 64·0–73·0 | 60·0–70·0 | 59·0–68·0 | 60·0–69·0 | |||||
| Sex | 0·938 | ||||||||
| Male | 189 | 39·1 | 180 | 37·2 | 183 | 37·7 | 184 | 38·0 | |
| Female | 294 | 60·9 | 304 | 62·8 | 302 | 62·3 | 300 | 62·0 | |
| BMI (kg/m2) | |||||||||
| BMI < 18·50 (underweight) | 9 | 1·9 | 22 | 4·5 | 13 | 2·7 | 12 | 2·5 | 0·010 |
| 18·50 ≤ BMI < 24·00 (normal weight) | 165 | 34·2 | 204 | 42·1 | 202 | 41·6 | 174 | 36·0 | |
| 24·00 ≤ BMI < 28·00 (overweight) | 203 | 42·0 | 185 | 38·2 | 180 | 37·1 | 197 | 40·7 | |
| BMI ≥ 28·00 (obese) | 106 | 21·9 | 73 | 15·1 | 90 | 18·6 | 101 | 20·9 | |
| Residence | 0·520 | ||||||||
| Urban | 126 | 26·1 | 140 | 28·9 | 141 | 29·1 | 125 | 25·8 | |
| Rural | 357 | 73·9 | 344 | 71·1 | 344 | 70·9 | 359 | 74·2 | |
| Employment | 0·174 | ||||||||
| No | 427 | 88·4 | 409 | 84·5 | 406 | 83·7 | 415 | 85·7 | |
| Yes | 56 | 11·6 | 75 | 15·5 | 79 | 16·3 | 69 | 14·3 | |
| Education | 0·089 | ||||||||
| Illiteracy | 122 | 25·3 | 133 | 27·5 | 108 | 22·3 | 118 | 24·4 | |
| Primary school | 174 | 36·0 | 158 | 32·6 | 150 | 30·9 % | 147 | 30·4 | |
| Junior high school/above | 187 | 38·7 | 193 | 39·9 | 227 | 46·8 | 219 | 45·2 | |
| Tobacco smoking | 0·485 | ||||||||
| No | 399 | 82·6 | 407 | 84·1 | 418 | 86·2 | 405 | 83·7 | |
| Yes | 84 | 17·4 | 77 | 15·9 | 67 | 13·8 | 79 | 16·3 | |
| Physical activities | 0·296 | ||||||||
| Light (<600 MET/week) | 139 | 28·8 | 137 | 28·3 | 135 | 27·8 | 135 | 27·9 | |
| Moderate (600–3000 MET/week) | 240 | 49·7 | 236 | 48·8 | 235 | 48·5 % | 233 | 48·1 | |
| Vigorous (>3000 MET/week) | 104 | 21·5 | 111 | 22·9 | 115 | 23·7 | 116 | 24·0 | |
| Median | IQR | Median | IQR | Median | IQR | Median | IQR | ||
| Glucose (mg/dl) | 5·60 | 5·14–6·40 | 5·57 | 5·11–6·28 | 5·49 | 5·05–6·28 | 5·60 | 5·07–6·26 | 0·268 |
| TAG (mg/dl) | 1·48 | 1·06–2·08 | 1·35 | 0·95–1·90 | 1·35 | 0·99–1·98 | 1·36 | 1·02–1·98 | 0·012 |
| HDL-cholesterol (mg/dl) | 1·24 | 1·04–1·49 | 1·33 | 1·08–1·59 | 1·30 | 1·10–1·56 | 1·26 | 1·06–1·51 | 0·012 |
| Systolic BP (mmHg) | 135 | 125·0–147·0 | 132 | 121·0–144·0 | 132·5 | 122·0–143·0 | 134 | 122·0–145·0 | 0·007 |
| Diastolic BP (mmHg) | 82 | 75·0–89·0 | 81 | 75·0–90·0 | 82 | 75·0–89·0 | 81·8 | 75·0–89·0 | 0·977 |
| Waist circumference (cm) | 90 | 84·0–97·1 | 90 | 82·0–97·0 | 89 | 83·2–96·0 | 90 | 84·0–96·2 | 0·489 |
DII, dietary inflammatory index; MET, metabolic equivalent.
Quartile 1: −5·24–0·81; Quartile 2: 0·81–1·81; Quartile 3: 1·81–2·54; Quartile 4: 2·54–5·59.
OR (95 % CI) for metabolic syndrome and its components in the community cohort study of nervous system diseases (CCSNSD) project population across quartiles of the DII score*
(Odds ratio and 95 % confidence intervals)
| DII | Metabolic syndrome | Hyperglycaemia | TAG | HDL-cholesterol | Hypertension | Abdominal obesity | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OR | 95 % CI | OR | 95 % CI | OR | 95 % CI | OR | 95 % CI | OR | 95 % CI | OR | 95 % CI | |
| Quartile 1 ( | 1·00 (Ref) | 1·00 (Ref) | 1·00 (Ref) | 1·00 (Ref) | 1·00 (Ref) | 1·00 (Ref) | ||||||
| Quartile 2 ( | 1·07 | 0·69, 1·35 | 1·05 | 0·76, 1·23 | 1·13 | 0·69, 1·33 | 0·86 | 0·63, 1·09 | 1·03 | 0·68, 1·19 | 1·21 | 1·06, 1·68 |
| Quartile 3 ( | 1·16 | 0·73, 1·46 | 1·13 | 0·98, 1·37 | 1·21 | 0·89, 1·36 | 0·95 | 0·65, 1·16 | 1·17 | 0·65, 1·32 | 1·48 | 1·12, 1·89 |
| Quartile 4 ( | 1·28 | 1·08, 1·56 | 1·23 | 1·05, 1·49 | 1·39 | 1·12, 1·65 | 1·08 | 0·73, 1·26 | 1·28 | 1·09, 1·51 | 1·59 | 1·18, 2·06 |
|
| 0·03 | 0·04 | 0·02 | 0·39 | 0·03 | 0·01 | ||||||
Multiple linear regression was used. All models were adjusted for age, sex, educational level, residence, employment status, tobacco smoking and physical activity. DII, dietary inflammatory index; Ref, reference.
Metabolic syndrome was defined following the National Cholesterol Education Program Adult Treatment Panel III recommendations, which consider the presence of ≥ 3 of the following components shown in footnotes 3–7.
Hyperglycaemia > 100 mg/dl.
Hypertriglyceridaemia > 150 mg/dl.
HDL-cholesterol: < 40 mg/dl in males or < 50 mg/dl in females.
Hypertension: systolic > 130 mmHg or diastolic > 85 mmHg.
Abdominal obesity > 102 cm for males or > 88 cm for females.
Subgroup analysis of association between dietary inflammatory index and sex hormones among different BMI groups in CCSNSD 2017–2018
(Odd ratio and 95 % confidence intervals)
| Dietary Inflammatory Index Group | Dyslipidaemia | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Metabolic syndrome ( | Hyperglycaemia ( | TAG ( | HDL-cholesterol ( | Hypertension ( | Abdominal obesity ( | |||||||
| OR | 95 % CI | OR | 95 % CI | OR | 95 % CI | OR | 95 % CI | OR | 95 % CI | OR | 95 % CI | |
| BMI < 18·50 (underweight) | ||||||||||||
| Quartile 1 ( | 1·00 (Ref) | 1·00 (Ref) | 1·00 (Ref) | 1·00 (Ref) | 1·00 (Ref) | 1·00 (Ref) | ||||||
| Quartile 2 ( | 1·12 | 0·39, 1·89 | 0·59 | 0·25, 1·13 | 1·05 | 0·67, 1·16 | 0·87 | 0·35, 1·36 | 0·92 | 0·57, 1·32 | 1·08 | 0·39, 2·87 |
| Quartile 3 ( | 1·39 | 0·58, 2·03 | 1·09 | 0·35, 1·96 | 1·12 | 0·86, 1·39 | 1·15 | 0·86, 1·67 | 1·25 | 0·81, 2·32 | 1·35 | 0·60, 3·12 |
| Quartile 4 ( | 1·62 | 0·67, 2·86 | 0·63 | 0·32, 3·02 | 1·19 | 0·82, 1·56 | 1·08 | 0·62, 1·58 | 1·58 | 0·93, 2·96 | 1·46 | 0·82, 3·69 |
| | 0·52 | 0·49 | 0·23 | 0·61 | 0·42 | 0·16 | ||||||
| 18·50 ≤ BMI < 24·00 (normal weight) | ||||||||||||
| Quartile 1 ( | 1·00 (Ref) | 1·00 (Ref) | 1·00 (Ref) | 1·00 (Ref) | 1·00 (Ref) | 1·00 (Ref) | ||||||
| Quartile 2 ( | 1·05 | 0·62, 1·63 | 1·03 | 0·67, 1·62 | 0·86 | 0·49, 1·31 | 0·69 | 0·46, 1·21 | 1·06 | 0·69, 1·56 | 1·23 | 0·72, 2·08 |
| Quartile 3 ( | 1·09 | 0·56, 1·56 | 1·25 | 0·79, 1·93 | 1·13 | 0·49, 1·37 | 1·05 | 0·68, 1·63 | 0·72 | 0·43, 1·19 | 1·45 | 0·86, 2·39 |
| Quartile 4 ( | 1·16 | 0·72, 1·85 | 1·29 | 0·85, 1·98 | 1·28 | 0·62, 1·59 | 1·26 | 0·78, 2·02 | 1·12 | 0·67, 1·75 | 1·08 | 0·60, 1·76 |
| | 0·83 | 0·37 | 0·63 | 0·17 | 0·32 | 0·57 | ||||||
| 24·00 ≤ BMI < 28·00 (overweight) | ||||||||||||
| Quartile 1 ( | 1·00 (Ref) | 1·00 (Ref) | 1·00 (Ref) | 1·00 (Ref) | 1·00 (Ref) | 1·00 (Ref) | ||||||
| Quartile 2 ( | 1·09 | 0·73, 1·68 | 1·03 | 0·53, 1·25 | 1·15 | 0·57, 1·52 | 0·86 | 0·58, 1·26 | 0·82 | 0·53, 1·26 | 1·78 | 1·12, 2·90 |
| Quartile 3 ( | 1·15 | 0·59, 2·23 | 1·12 | 0·64, 1·36 | 1·26 | 0·57, 1·90 | 1·01 | 0·62, 1·34 | 1·12 | 1·03, 1·26 | 2·02 | 1·28, 3·19 |
| Quartile 4 ( | 1·23 | 0·67, 2·41 | 1·18 | 1·05, 1·62 | 1·67 | 0·79, 2·16 | 1·12 | 0·73, 1·49 | 1·35 | 1·13, 1·96 | 2·28 | 1·36, 3·62 |
| | 0·57 | 0·02 | 0·19 | 0·25 | 0·01 | 0·008 | ||||||
| BMI ≥ 28·00 (obese) | ||||||||||||
| Quartile 1 ( | 1·00 (Ref) | 1·00 (Ref) | 1·00 (Ref) | 1·00 (Ref) | 1·00 (Ref) | 1·00 (Ref) | ||||||
| Quartile 2 ( | 1·08 | 0·96, 2·05 | 1·06 | 0·76, 1·52 | 1·15 | 0·65, 1·96 | 1·03 | 0·52, 1·86 | 0·76 | 0·39, 1·47 | 1·26 | 1·05, 1·89 |
| Quartile 3 ( | 1·63 | 1·06, 2·18 | 1·23 | 1·08, 1·68 | 1·29 | 0·75, 2·02 | 1·19 | 0·48, 1·65 | 1·08 | 0·62, 2·06 | 1·52 | 1·16, 2·35 |
| Quartile 4 ( | 2·15 | 1·08, 3·28 | 1·42 | 1·15, 1·92 | 1·56 | 1·06, 2·32 | 1·35 | 0·97, 2·56 | 1·36 | 1·12, 2·32 | 2·01 | 1·20, 3·06 |
| | 0·02 | 0·006 | 0·03 | 0·26 | 0·009 | 0·006 | ||||||